Company Valuation: NovoCure Limited

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 8,340 17,615 7,795 7,698 1,595 2,407 2,407 -
Change - 111.21% -55.75% -1.24% -79.27% 50.9% 0% -
Enterprise Value (EV) 1 8,312 17,810 8,148 8,148 1,923 2,229 2,367 2,294
Change - 114.27% -54.25% 0% -76.39% 15.88% 6.18% -3.07%
P/E ratio -1,204x 865x -134x -83.4x -7.66x -17.2x -13.9x -13.8x
PBR 38.5x 37.2x 19x - - - - -
PEG - -2x 0x -1.5x -0x 0.5x -0.6x -20.74x
Capitalization / Revenue 23.7x 35.6x 14.6x 14.3x 3.13x 3.98x 3.91x 3.55x
EV / Revenue 23.7x 36x 15.2x 15.1x 3.78x 3.68x 3.84x 3.38x
EV / EBITDA 1,102x 450x -239x -103x -8.67x -15.6x -13.6x -13.8x
EV / EBIT -9,094x 586x -184x -91x -8.26x -14.9x -12.6x -12.3x
EV / FCF 515x 212x 139x 864x -19.2x -9.11x -32.2x -17.9x
FCF Yield 0.19% 0.47% 0.72% 0.12% -5.22% -11% -3.11% -5.58%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -0.07 0.2 -0.56 -0.88 -1.95 -1.296 -1.598 -1.608
Distribution rate - - - - - - - -
Net sales 1 351.3 494.4 535 537.8 509.3 605.2 616.1 678.6
EBITDA 1 7.546 39.55 -34.08 -78.9 -221.9 -143.2 -173.6 -166.4
EBIT 1 -0.914 30.4 -44.33 -89.52 -232.9 -149.4 -188 -187
Net income 1 -7.23 19.81 -58.35 -92.53 -207 -140 -176.9 -179.5
Net Debt 1 -27.9 195.2 353.4 450.2 328 -178.6 -40.89 -113.5
Reference price 2 84.27 173.04 75.08 73.35 14.93 22.25 22.25 22.25
Nbr of stocks (in thousands) 98,969 101,797 103,819 104,950 106,861 108,201 108,201 -
Announcement Date 2/27/20 2/25/21 2/24/22 2/23/23 2/22/24 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

Add to a list
P/E ratio (N) EV / Sales (N) EV / EBITDA (N) Yield (N) Capi.($)
-17.16x3.68x-15.56x - 2.41B
616.11x8.16x62.83x-.--% 10B
100.73x3.56x19.11x - 9.43B
28.76x1.99x11.74x2.1% 5.29B
51.49x - - 0.5% 4.93B
17.35x - - 1.63% 4.93B
-67.4x7.7x-120.56x-.--% 4.68B
35.44x5.52x18.08x0.94% 4.57B
47.67x - - 0.46% 1.43B
Average 90.33x 5.10x -4.06x percentage-no-prefix 5.3B
Weighted average by Cap. 156.86x 5.38x 9.65x percentage-no-prefix
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. NVCR Stock
  4. Valuation NovoCure Limited